A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

Maintaining a healthy weight is good for your body and can also help with self-esteem. If you’ve been trying to lose weight, ...

PEOPLE TAKING GLP-1S have a reduced risk of heart attacks, strokes, and death from cardiovascular disease, according to a ...

Heavy drinkers who were ­taking weight-loss jabs in a Dublin clinic significantly reduced their ­alcohol intake down from 12 ...

Liraglutide (Victoza) for type 2 diabetes is exactly the same drug as Saxenda for weight loss, but Saxenda is a higher dose. Although the target for each formulation is the same (the GLP-1 ...

the active ingredient in the company's older weight loss medicine Saxenda and diabetes drug Victoza, per Reuters. The researchers compared the drugs to bupropion-naltrexone, the active ingredient ...

Saxenda, in comparison to Victoza, is approved by the FDA as a weight loss drug. However, know that Saxenda is dosed differently than Victoza; therefore, they are not interchangeable. As a GLP-1 ...

Apart from Victoza, which was approved for Type 2 diabetes in 2010, liraglutide also underpins Novo’s older weight loss drug Saxenda and its insulin-degludec-based diabetes combination therapy ...

said she hoped generic liraglutide’s price “will be significantly lower than name brand Victoza and Saxenda, but lessons from other drugs that are available as generics teach us that this ...

Novo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as Victoza ... of its lucrative diabetes and weight-loss drugs off the market.

The approval covers generic versions of two Novo Nordisk products: Victoza, used in the treatment of Type-2 Diabetes, and Saxenda ... diabetes management and weight loss treatment.